Literature DB >> 8660654

Ubiquitous expression and cell cycle regulation of the protein kinase PIM-1.

H Liang1, W Hittelman, L Nagarajan.   

Abstract

The murine pim-1 gene, isolated as a locus frequently activated by proviral integration in T cell lymphomas, encodes a protein serine kinase. Although genetic evidence suggests a crucial role for this protooncogene in cell growth and transformation, very little is known about its protein product. The murine pim-1 mRNA provides alternate translational starts at a CUG codon +87-89 and an AUG codon at +339-341, in the same open reading frame (ORF), resulting in 44-kDa (397 amino acids) and 34-kDa (313 amino acids) isoforms. In this report, we demonstrate that the human PIM-1 mRNA is translated only from the single initiation methionine codon at +339-341 under cell-free conditions. Immunoblotting analyses of several human solid tumor cell lines, with highly specific antisera reveal two ubiquitously expressed isoforms (35 and 34 kDa). The estimated half-life of these proteins is shorter in the normal peripheral blood leukocytes (<5 min) than in the chronic myelogenous leukemia cells K562 (<20 min). Immunoblotting analyses of centrifugally elutriated fractions of the chronic myelogenous leukemia BV173 cells demonstrate that the levels of PIM-1 increase during the progression from early to late GI, remain high at the G1/S boundary and G2 phases of the cell cycle. The results presented here suggest a ubiquitous role for PIM-1 in progression through cell cycle.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8660654     DOI: 10.1006/abbi.1996.0251

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  19 in total

1.  Pim kinase expression is induced by LTP stimulation and required for the consolidation of enduring LTP.

Authors:  U Konietzko; G Kauselmann; J Scafidi; U Staubli; H Mikkers; A Berns; M Schweizer; R Waltereit; D Kuhl
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

Review 2.  Myocardial AKT: the omnipresent nexus.

Authors:  Mark A Sussman; Mirko Völkers; Kimberlee Fischer; Brandi Bailey; Christopher T Cottage; Shabana Din; Natalie Gude; Daniele Avitabile; Roberto Alvarez; Balaji Sundararaman; Pearl Quijada; Matt Mason; Mathias H Konstandin; Amy Malhowski; Zhaokang Cheng; Mohsin Khan; Michael McGregor
Journal:  Physiol Rev       Date:  2011-07       Impact factor: 37.312

3.  Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.

Authors:  J S Foster; D C Henley; A Bukovsky; P Seth; J Wimalasena
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

Review 4.  Why target PIM1 for cancer diagnosis and treatment?

Authors:  Nancy S Magnuson; Zeping Wang; Gang Ding; Raymond Reeves
Journal:  Future Oncol       Date:  2010-09       Impact factor: 3.404

5.  Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation.

Authors:  Magdalena Delgado; Anisha Kothari; Walter N Hittelman; Timothy C Chambers
Journal:  J Vis Exp       Date:  2017-11-10       Impact factor: 1.355

6.  Overexpression of Pim-1 during progression of prostatic adenocarcinoma.

Authors:  T L Cibull; T D Jones; L Li; J N Eble; L Ann Baldridge; S R Malott; Y Luo; L Cheng
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

Review 7.  PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers.

Authors:  Laurent Brault; Christelle Gasser; Franz Bracher; Kilian Huber; Stefan Knapp; Jürg Schwaller
Journal:  Haematologica       Date:  2010-02-09       Impact factor: 9.941

8.  PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis.

Authors:  Xiu Feng Hu; Jie Li; Scott Vandervalk; Zeping Wang; Nancy S Magnuson; Pei Xiang Xing
Journal:  J Clin Invest       Date:  2009-01-19       Impact factor: 14.808

9.  The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells.

Authors:  Marina Zemskova; Eva Sahakian; Svetlana Bashkirova; Michael Lilly
Journal:  J Biol Chem       Date:  2008-04-21       Impact factor: 5.157

Review 10.  Mitochondrial integrity: preservation through Akt/Pim-1 kinase signaling in the cardiomyocyte.

Authors:  Mark A Sussman
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.